Innovating.works Conecta tu I+D

Mostrando 1 al 20 de 44 resultados

FARAON: De novo Synthesis of Fluoroarenes and Fluoro(hetero)arenes LATVIJAS ORGANISKAS SINTEZES INSTITUTS tramitó un HORIZON EUROPE: HORIZON-WIDERA-2023-TALENTS-02 Historically, one of the biggest challenges in synthetic organic chemistry has always been to synthesize fluoroarenes (Ar-F) and fluoroheter...
2025-04-01 - 2027-03-31 | Financiado

MR LATVIA: Development of Magnetic Resonance in Latvia LATVIJAS ORGANISKAS SINTEZES INSTITUTS tramitó un HORIZON EUROPE: HORIZON-WIDERA-2023-ACCESS-02 The aim of the MR LATVIA project is to establish a regional centre of excellence in nuclear magnetic resonance (NMR) at the Latvian Institut...
2024-09-01 - 2027-08-31 | Financiado

FARAON: De novo Synthesis of Fluoroarenes and Fluoro hetero arenes Historically, one of the biggest challenges in synthetic organic chemistry has always been to synthesize fluoroarenes (Ar-F) and fluoroheter...
2024-07-29 - 2027-03-31 | Financiado

WIDEnzymes: Widening Synergies for Novel Enzymes Development LATVIJAS ORGANISKAS SINTEZES INSTITUTS tramitó un HORIZON EUROPE: HORIZON-WIDERA-2023-ACCESS-04 "The ""Widening Synergies for Novel Enzymes Development"" (WIDEnzymes) project aims to foster the creation of a unique cross-border collabor...
2024-04-01 - 2027-03-31 | Financiado

BIOCONNECT: BIOCONNECT Developing the Action Plan to Foster Baltic Region Innovation Ecosystem in Biotechnology... LATVIJAS ORGANISKAS SINTEZES INSTITUTS participó en un HORIZON EUROPE: HORIZON-EIE-2022-CONNECT-01 The BIOCONNECT project aims to help create a more robust, integrated, and inclusive Baltic ecosystem/cluster for biotechnology innovation as...
2023-11-10 - 2024-11-30 | Financiado

PHOTOTHERAPORT: LUMINESCENT IMPLANTS AS PORTS FOR LIGHT BASED THERAPIES LATVIJAS ORGANISKAS SINTEZES INSTITUTS participó en un HORIZON EUROPE: HORIZON-EIC-2023-PATHFINDEROPEN-01 A major difficulty in developing clinically useful treatments is to deliver therapeutic action with spatiotemporal precision and pharmacolog...
2023-10-31 - 2026-12-31 | Financiado

Natalion: Natural Products Research at Latvian Institute of Organic Synthesis as a driver for Excellence in In... LATVIJAS ORGANISKAS SINTEZES INSTITUTS tramitó un HORIZON EUROPE: HORIZON-WIDERA-2022-TALENTS-01 The aim of Natalion is to foster innovation excellence of LIOS by the establishment of the Natural Products Research (NPR) group and impleme...
2023-01-01 - 2027-12-31 | Financiado

Fragment-Screen: From fragments to high affinity binders interfacing integrated structural biology medicinal chemist... LATVIJAS ORGANISKAS SINTEZES INSTITUTS participó en un HORIZON EUROPE: HORIZON-INFRA-2022-TECH-01 Fragment-Screen will develop innovative instrumentation, workflows and experimental and computational methodologies for fragment-based drug...
2022-12-13 - 2026-01-31 | Financiado

TransPharm: Transforming into a sustainable European pharmaceutical sector LATVIJAS ORGANISKAS SINTEZES INSTITUTS participó en un HORIZON EUROPE: HORIZON-HLTH-2021-IND-07 TransPharm two-track approach focusses on the one hand on the compounds itself by identifying greener and more sustainable-by-design Active...
2022-05-19 - 2026-05-31 | Financiado

R-NMR: Remote NMR (R-NMR): Moving NMR infrastructures to remote access capabilities LATVIJAS ORGANISKAS SINTEZES INSTITUTS participó en un HORIZON EUROPE: HORIZON-INFRA-2021-DEV-01 Nuclear magnetic resonance spectroscopy (NMR) is one of the major analytical methods applied in all chemical, physical, biological, and medi...
2022-04-11 - 2025-06-30 | Financiado

ISIDORe: Integrated Services for Infectious Disease Outbreak Research LATVIJAS ORGANISKAS SINTEZES INSTITUTS participó en un HORIZON EUROPE: HORIZON-INFRA-2021-EMERGENCY-02 The ISIDORe consortium, made of the capacities of European ESFRI infrastructures and coordinated networks, proposes to assemble the largest...
2022-02-09 - 2025-07-31 | Financiado

Oligomers-MAS-NMR: Structure determination of amyloid oligomers the pathogenic species in Alzheimer s disease using f... LATVIJAS ORGANISKAS SINTEZES INSTITUTS tramitó un H2020: H2020-WF-2018-2020 Alzheimer’s disease (AD) is an age-related neurodegenerative disorder responsible for about 2 million deaths per year. Despite tremendous pr...
2021-03-31 - 2023-11-30 | Financiado

RISK-HUNT3R: RISK assessment of chemicals integrating HUman centric Next generation Testing strategies promoting... LATVIJAS ORGANISKAS SINTEZES INSTITUTS participó en un H2020: H2020-SC1-BHC-2018-2020 The vision of the RISK-HUNT3R consortium is to develop a reliable, efficient and cost-effective chemical safety assessment approach. It will...
2021-01-22 - 2026-05-31 | Financiado

A4L_ACTIONS: Alliance for Life Sciences From Strategies to Actions in Central and Eastern Europe LATVIJAS ORGANISKAS SINTEZES INSTITUTS participó en un H2020: H2020-SC1-BHC-2018-2020 The gap in Research and Innovation (R&I) performance, which persists despite considerable investments from the European Structural and Inves...
2020-12-11 - 2024-04-30 | Financiado

ALISE: Anti Cancer Light Controllable Antibody Peptide Conjugates LATVIJAS ORGANISKAS SINTEZES INSTITUTS participó en un H2020: H2020-MSCA-RISE-2020 Project ALISE (Antibody Light-Induced Selectivity Enhancement) will integrate the expertise, resources and knowledge of participating Instit...
2020-10-19 - 2026-02-28 | Financiado

SPRINGBOARD: Springboard for excellence in advanced development of antibacterials LATVIJAS ORGANISKAS SINTEZES INSTITUTS tramitó un H2020: H2020-WIDESPREAD-2018-2020 The main goal of SPRINGBOARD project is to strengthen research potential of the Latvian Institute of Organic Synthesis (LIOS) through establ...
2020-06-10 - 2024-05-31 | Financiado

ERA4TB: EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS LATVIJAS ORGANISKAS SINTEZES INSTITUTS participó en un H2020: H2020-JTI-IMI2-2018-15-two-stage The European Regimen Accelerator for Tuberculosis (ERA4TB) has the explicit goal of developing a new combination therapy to treat all forms...
2019-12-12 - 2025-12-31 | Financiado

InterTAU: Integrative structural biology of pathological tau protein an appealing therapeutic target for Alzh... LATVIJAS ORGANISKAS SINTEZES INSTITUTS participó en un H2020: H2020-MSCA-RISE-2019 There is an enormous and unmet medical need to find efficient methods of prevention, diagnosis and disease- modifying therapies for neurodeg...
2019-11-27 - 2025-06-30 | Financiado